SK Biopharmaceuticals Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - SK Biopharmaceuticals Co Ltd

Watchlist Manager

Watchlist

Price: 75 900 KRW -1.3% Market Closed

Market Cap: ₩5.9T

	SK Biopharmaceuticals Co Ltd KRX:326030	KR
F	Fresnillo PLC F:FNL	MX

Profitability Summary

SK Biopharmaceuticals Co Ltd's profitability score is 84/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

94%

Strong 3Y Average Gross Margin

92%

Gross Margin is Increasing

87% > 94%

Exceptional Operating Margin

35%

Sustainable 3Y Average Operating Margin

14%

Operating Margin is Increasing

-27% > 35%

Exceptional Net Margin

47%

Sustainable 3Y Average Net Margin

23%

Net Margin is Increasing

-29% > 47%

Exceptional Free Cash Flow Margin

25%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-51% > 25%

Exceptional ROE

50%

Exceptional 3Y Average ROE

Exceptional 3Y Average ROIC

30%

ROIC is Increasing

-21% > 47%

View All

Hide

Collapse

84 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.